Corporate news
Grifols donates over 25 million international units of blood clotting factor in 2017 Part of an eight-year commitment to WFH; Changing the lives of people with hemophilia in 47 countries with limited access to treatment
+ info
+ info
Grifols and IrsiCaixa join forces to promote biomedical research on HIV and associated diseases In alignment with its ongoing commitment to innovation, Grifols will contribute EUR 1.5 million every year for 5 years through the Grifols Innovation and New Technologies Office.
+ info
+ info
Grifols concludes the experimental phase of AMBAR, a clinical trial on Alzheimer's disease Grifols initiated its Alzheimer's research in 2004
+ info
+ info
Highlights
Manufacturing
We are a solid company with an international dimension.
Corporate Commitment
We contribute to improving people's health and wellbeing by offering safe, high quality products produced using the latest environmentally friendly technology.
When a Dream Comes True. An Illustrated History of 75 Years of Grifols
Read When a Dream Comes True: An illustrated history of 75 years of Grifols to discover the company's roots, and learn more about our history and the development of the company. + info